Developer docs
API playgroundTry for free, no card

Search company profiles

DNAstack

Full company profile

uuid00078b7

Namestring
DNAstack
Legal namestring
DNAstack Corp.
Websiteurl
dnastack.com
Company typeenum
Private
Founded yearint
2014
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersToronto, Canada
HQ citystring
Toronto
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
genomics data platform, federated AI software, biomedical data sharing, omics analysis tools, health data interoperability
Industry3 codes
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)
NAICS code2 codes
  • Software Publishers5132
  • Computer Systems Design and Related Services5415
SIC code3 codes
  • Services-Prepackaged Software7372
  • Services-Computer Processing & Data Preparation7374
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Genomics Software Platform
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model3 records
1Enterprise Software Licensing
TypeSubscription Recurring
Description

Platform access via enterprise-level agreements with organizations, including data custodians and consumers, with licensing terms negotiated based on organizational needs and usage.

dnastack.com
2SaaS Platform Access
TypeSubscription Recurring
Description

Direct sign-up and payment through website with fees, payment schedule and authorization terms presented at sign-up. Both free and paid accounts available.

dnastack.com
3Professional Services
TypeProfessional Services
Description

Bioinformatics, data integration, machine learning, visualization, software engineering, and project management services.

dnastack.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales
Pricing details2 tiers
1Enterprise Level Agreement - Custom licensing for organizations with contractual relationships
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Organizational access governed by enterprise agreements; pricing negotiated based on scope and requirements

dnastack.com
2Direct Website Access - Self-serve and paid account options
ModelSubscriptionBilling cadenceMonthly
Notes

Fees, payment schedule and payment authorization terms presented at time of sign-up

dnastack.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 8 records shown
1Omics AI
Description

A federated insights platform for omics and health data that enables analysis across distributed datasets without centralizing sensitive patient information.

dnastack.com
+7 more records
Core offering1 text field

DNAstack builds Omics AI, a federated AI software suite that enables data custodians to connect, protect, and share omics and health data over GA4GH open standards while allowing researchers to make AI-powered discoveries across distributed networks without moving patient data. The suite consists of Workbench (analysis execution), Publisher (data sharing), Explorer (federated discovery), Workflows (curated pipelines), and Tertiary Analysis (Network Intelligence interpretation), and powers disease-specific federated networks such as Viral AI, Neuroscience AI, Rare Disease AI, and HiFi Solves.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 10-15% increase in diagnostic yield for rare disease patients
+4 more records
Product overview1 text field

DNAstack offers Omics AI as its flagship software platform—a federated insights platform for omics and health data. The platform consists of four core modules: Workbench for analysis execution, Publisher for data connection and sharing, Explorer for federated data discovery, and Workflows for curated analysis pipelines. Tertiary Analysis was added as a specialized genomic interpretation layer. The company also operates several disease-specific federated networks (sub-brands) including Viral AI (infectious disease), Neuroscience AI, Rare Disease AI, Biomedical AI, and Oncology AI (coming soon), plus the HiFi Solves network for long-read rare disease research. Together these products enable AI-powered insights across distributed genomic and health data without centralizing sensitive patient information.

Product and service12 records
1Omics AI
CategoryFederated genomics software platform
Description

Flagship software suite for data custodians and researchers to connect, protect, share, and analyze omics and health data across federated networks without moving patient data, built on GA4GH open standards.

2Workbench
CategoryOmics analysis module
Description

Standards-compliant solution for analyzing omics and health data within the user's own environment, functioning as the workflow execution manager for running computational pipelines.

3Publisher
CategoryData sharing module
Description

Tool for connecting, protecting, and sharing omics and health data over open industry standards, enabling data custodians to organize and share their data.

4Explorer
CategoryFederated data discovery portal
Description

Brandable portal that brings together federated data and makes them uniformly findable, accessible, and analyzable for data discovery.

5Workflows
CategoryAnalysis pipeline marketplace
Description

Marketplace of curated best-practice computational pipelines for analyzing omics data from popular sequencing instruments including PacBio, Illumina, and Oxford Nanopore.

6Tertiary Analysis
CategoryGenomic interpretation software
Description

Genomic interpretation layer powered by Network Intelligence that runs best-practice secondary and tertiary analysis pipelines on HiFi genome data and combines insights from across the network with AI-powered interpretation.

7Viral AI
CategoryDisease-specific federated network
Description

Global federated network for genomic surveillance and infectious disease research, processing viral genome sequences for pandemic surveillance.

8Neuroscience AI
CategoryDisease-specific federated network
Description

Global federated network for neuroscience research, powering collaborative research in autism and other neurological conditions.

9Rare Disease AI
CategoryDisease-specific federated network
Description

Global federated network for rare disease research, enabling privacy-preserving AI-powered insights across distributed datasets.

10Biomedical AI
CategoryDisease-specific federated network
Description

Global federated network for biomedical research, enabling collaborative discovery across distributed biomedical datasets.

11HiFi Solves
CategoryDisease-specific federated network
Description

Global network of long-read sequencing and associated phenotype data connected across institutions to accelerate rare disease research, launched by PacBio and DNAstack.

12Professional Services
CategoryProfessional services
Description

Bioinformatics, data integration, machine learning, visualization, software engineering, and project management services delivered alongside the Omics AI platform.

Scale indicator14 records

Each record includes

Type, Value, Description, Source

Partnership16 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-05-07
Description

Partnership to deliver integrated clinical genetics workflow platform running from patient intake to diagnostic report entirely on Canadian infrastructure. Combines Omics AI with PhenoTips' clinical genomics system.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2026-02-24
Description

Global partnership to launch world's first federated HiFi whole genome sequencing dataset through HiFi Solves Global Consortium. Enables secure international research collaboration while maintaining institutional data control across 15 countries and 10,000+ genomes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Led Canadian COVID-19 Genomics Network (CanCOGeN) viral genomics surveillance initiatives. Viral AI platform processed 550,000+ SARS-CoV-2 genomes tracking 1,600+ lineages.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

MSSNG project partnership powering world's largest autism whole-genome sequencing database with 13,800+ individuals. Contributed to 138 published papers and identification of 100+ genes.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Launched first-of-its-kind data portal providing no-strings-attached access to comprehensive ALS datasets and analysis tools for therapeutic discovery research.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Collaboration on autism genomics research through MSSNG project. SickKids houses the world's largest autism whole-genome sequencing database.

7Holland Bloorview Kids Rehabilitation Hospital
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Federated learning analysis of medication use patterns in children with neurodevelopmental conditions through POND Network. Generated insights on medication prescription biases.

dnastack.com
Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Clinical trial data sharing in neuroscience through federated platform. Partnership through Autism Sharing Initiative and COVID Cloud consortium.

9ASAP/Michael J. Fox Foundation
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Launched ASAP Collaborative Research Network Cloud Platform powered by Omics AI to unite Parkinson's disease data analysis efforts across global research community.

dnastack.com
10Canada's Digital Technology Supercluster
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Led multiple federally funded Supercluster initiatives representing over $50 million in combined investment. Autism Sharing Initiative ($11.2M), Canadian Platform for Genomics ($14.5M), COVID Cloud ($5.1M).

dnastack.com
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Partnership on COVID-19 response and viral genomics surveillance. Delivered Canada's national viral genomics surveillance platform.

Strategic tierSecondaryTypeStrategic or Co-development Partner
Description

Bronze sponsorship partnership with globally-renowned AI Institute to accelerate AI-based innovation in Canada through industry-academia collaboration.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Founding contributor to GA4GH open standards including data access, discovery, and cloud computing APIs. Co-author of HL7 FHIR specifications.

14Microsoft Azure
Strategic tierSecondaryTypeTechnology or Integration
Description

Third-party cloud infrastructure provider for platform hosting. Listed as approved deployment environment in terms of service.

dnastack.com
Strategic tierSecondaryTypeTechnology or Integration
Description

Third-party cloud infrastructure provider for platform hosting. Listed as approved deployment environment in terms of service.

Strategic tierSecondaryTypeTechnology or Integration
Description

Third-party cloud infrastructure provider for platform hosting. Listed as approved deployment environment in terms of service.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Tempus Labs
TypeEmerging player
Description

AI-driven precision medicine company combining clinical and molecular data for oncology and beyond. Adjacent on multi-omics + clinical AI, with stronger commercial reach in US oncology.

TypeDirect peer
Description

Provides a cloud-based genomics data management and analysis platform serving pharma, hospitals, and consortia. Direct competitor in federated/centralized genomics informatics with overlapping pharma and clinical customers.

TypeDirect peer
Description

Cloud genomics and multi-omics analysis platform with biomedical informatics tools for research and clinical use. Overlaps with DNAstack's workflow, tertiary analysis, and pharma-facing capabilities.

TypeBroad incumbent
Description

Dominant sequencing instrument vendor offering BaseSpace and Connected Software analytics. As an incumbent, it bundles sequencing + analysis and represents the broadest competitive threat in genomics workflows.

TypeDirect peer
Description

Clinical genomics interpretation platform using AI for variant prioritization and rare disease diagnosis. Overlaps with DNAstack's Tertiary Analysis module and rare disease network focus.

TypeDirect peer
Description

Genomics and real-world data platform with federated analytics capabilities serving national genome programs and pharma. Comparable on federated genomics + pharma data partnerships.

TypeDirect peer
Description

AI-powered genomics platform for clinical interpretation and rare disease/oncology analysis, distributed via hospital network. Competes on AI-driven tertiary interpretation and clinical genomics workflow.

TypeBroad incumbent
Description

Hyperscaler offering HealthOmics for genomics, transcriptomics, and multi-omics workflows. Competes on integrated cloud + analytics and benefits from existing hospital cloud contracts.

TypeDirect peer
Description

Federated genomics and biomedical data platform built on open standards, serving national genomics initiatives and pharma. Closest direct competitor on federated architecture and GA4GH compliance positioning.

TypeBroad incumbent
Description

Hyperscaler offering Genomics and Health Data Services on Azure, listed as approved DNAstack deployment environment. Bundles compute + analytics at scale and poses a long-term platform threat.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers10 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile5 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

Integration5 records

Each record includes

Title, Type, Description, Source

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

DNAstack

Genomics Software Platformdnastack.com

DNAstack firmographics

Firmographics
Name
DNAstack
Legal name
DNAstack Corp.
Website
https://dnastack.com
Company type
Private
Founded year
2014
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

DNAstack industry classification

Industry
Product category
Genomics Software Platform
NAICS
Software Publishers (5132), Computer Systems Design and Related Services (5415)
SIC
Services-Prepackaged Software (7372), Services-Computer Processing & Data Preparation (7374), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGANAI
Bioinformatics, Multi-Omics Data Analysis & Interpretation Services
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Specialty Lab Services (Genomics/Proteomics/Cellomics)
SECONDARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)

Keywords

  • Genomics data platform
  • Federated AI software
  • Biomedical data sharing
  • Omics analysis tools
  • Health data interoperability

Where DNAstack is headquartered

Location

Headquarters

HQ city
Toronto
HQ country
Canada
HQ region
North America

Offices1 record

Markets served

DNAstack business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Technology or R&D, Personnel, Infrastructure, Operations, Marketing or Sales

Revenue model

  1. Enterprise Software Licensing: Platform access via enterprise-level agreements with organizations, including data custodians and consumers, with licensing terms negotiated based on organizational needs and usage.
  2. SaaS Platform Access: Direct sign-up and payment through website with fees, payment schedule and authorization terms presented at sign-up. Both free and paid accounts available.
  3. Professional Services: Bioinformatics, data integration, machine learning, visualization, software engineering, and project management services.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise Level Agreement - Custom licensing for organizations with contractual relationships
SubscriptionMonthlyDirect Website Access - Self-serve and paid account options

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

DNAstack product offering

Product offering

Core offering

DNAstack builds Omics AI, a federated AI software suite that enables data custodians to connect, protect, and share omics and health data over GA4GH open standards while allowing researchers to make AI-powered discoveries across distributed networks without moving patient data. The suite consists of Workbench (analysis execution), Publisher (data sharing), Explorer (federated discovery), Workflows (curated pipelines), and Tertiary Analysis (Network Intelligence interpretation), and powers disease-specific federated networks such as Viral AI, Neuroscience AI, Rare Disease AI, and HiFi Solves.

Product overview

DNAstack offers Omics AI as its flagship software platform—a federated insights platform for omics and health data. The platform consists of four core modules: Workbench for analysis execution, Publisher for data connection and sharing, Explorer for federated data discovery, and Workflows for curated analysis pipelines. Tertiary Analysis was added as a specialized genomic interpretation layer. The company also operates several disease-specific federated networks (sub-brands) including Viral AI (infectious disease), Neuroscience AI, Rare Disease AI, Biomedical AI, and Oncology AI (coming soon), plus the HiFi Solves network for long-read rare disease research. Together these products enable AI-powered insights across distributed genomic and health data without centralizing sensitive patient information.

Differentiator

Problem solved

Functional benefit

Brands

  • Omics AI: A federated insights platform for omics and health data that enables analysis across distributed datasets without centralizing sensitive patient information.
  • Workbench
  • Publisher
  • Explorer
  • Viral AI
  • Neuroscience AI
  • Rare Disease AI
  • Biomedical AI

Products and services

  • Omics AI Flagship software suite for data custodians and researchers to connect, protect, share, and analyze omics and health data across federated networks without moving patient data, built on GA4GH open standards.
  • Workbench Standards-compliant solution for analyzing omics and health data within the user's own environment, functioning as the workflow execution manager for running computational pipelines.
  • Publisher Tool for connecting, protecting, and sharing omics and health data over open industry standards, enabling data custodians to organize and share their data.
  • Explorer Brandable portal that brings together federated data and makes them uniformly findable, accessible, and analyzable for data discovery.
  • Workflows Marketplace of curated best-practice computational pipelines for analyzing omics data from popular sequencing instruments including PacBio, Illumina, and Oxford Nanopore.
  • Tertiary Analysis Genomic interpretation layer powered by Network Intelligence that runs best-practice secondary and tertiary analysis pipelines on HiFi genome data and combines insights from across the network with AI-powered interpretation.
  • Viral AI Global federated network for genomic surveillance and infectious disease research, processing viral genome sequences for pandemic surveillance.
  • Neuroscience AI Global federated network for neuroscience research, powering collaborative research in autism and other neurological conditions.
  • Rare Disease AI Global federated network for rare disease research, enabling privacy-preserving AI-powered insights across distributed datasets.
  • Biomedical AI Global federated network for biomedical research, enabling collaborative discovery across distributed biomedical datasets.
  • HiFi Solves Global network of long-read sequencing and associated phenotype data connected across institutions to accelerate rare disease research, launched by PacBio and DNAstack.
  • Professional Services Bioinformatics, data integration, machine learning, visualization, software engineering, and project management services delivered alongside the Omics AI platform.

Quantifiable outcome

  • 10-15% increase in diagnostic yield for rare disease patients
  • +4 more outcomes

Companies that use DNAstack

Customer profile

Named customers10 records

Segments5 records

Ideal customer profiles5 records

DNAstack technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability7 records

Feature6 records

DNAstack partnerships and signals

Strategic signal

Partnerships

16 partnerships are on record, tiered core and secondary.

  • PhenoTipscoreStrategic or Co-development Partner · 7 May 2026Partnership to deliver integrated clinical genetics workflow platform running from patient intake to diagnostic report entirely on Canadian infrastructure. Combines Omics AI with PhenoTips' clinical genomics system.
  • PacBiocoreStrategic or Co-development Partner · 24 February 2026Global partnership to launch world's first federated HiFi whole genome sequencing dataset through HiFi Solves Global Consortium. Enables secure international research collaboration while maintaining institutional data control across 15 countries and 10,000+ genomes.
  • Genome CanadacoreStrategic or Co-development PartnerLed Canadian COVID-19 Genomics Network (CanCOGeN) viral genomics surveillance initiatives. Viral AI platform processed 550,000+ SARS-CoV-2 genomes tracking 1,600+ lineages.
  • Autism SpeakscoreStrategic or Co-development PartnerMSSNG project partnership powering world's largest autism whole-genome sequencing database with 13,800+ individuals. Contributed to 138 published papers and identification of 100+ genes.
  • Target ALScoreStrategic or Co-development PartnerLaunched first-of-its-kind data portal providing no-strings-attached access to comprehensive ALS datasets and analysis tools for therapeutic discovery research.
  • SickKidscoreStrategic or Co-development PartnerCollaboration on autism genomics research through MSSNG project. SickKids houses the world's largest autism whole-genome sequencing database.
  • Holland Bloorview Kids Rehabilitation HospitalsecondaryStrategic or Co-development PartnerFederated learning analysis of medication use patterns in children with neurodevelopmental conditions through POND Network. Generated insights on medication prescription biases.
  • RochesecondaryStrategic or Co-development PartnerClinical trial data sharing in neuroscience through federated platform. Partnership through Autism Sharing Initiative and COVID Cloud consortium.
  • ASAP/Michael J. Fox FoundationcoreStrategic or Co-development PartnerLaunched ASAP Collaborative Research Network Cloud Platform powered by Omics AI to unite Parkinson's disease data analysis efforts across global research community.
  • Canada's Digital Technology SuperclustercoreStrategic or Co-development PartnerLed multiple federally funded Supercluster initiatives representing over $50 million in combined investment. Autism Sharing Initiative ($11.2M), Canadian Platform for Genomics ($14.5M), COVID Cloud ($5.1M).
  • Ontario GenomicscoreStrategic or Co-development PartnerPartnership on COVID-19 response and viral genomics surveillance. Delivered Canada's national viral genomics surveillance platform.
  • Vector InstitutesecondaryStrategic or Co-development PartnerBronze sponsorship partnership with globally-renowned AI Institute to accelerate AI-based innovation in Canada through industry-academia collaboration.
  • Global Alliance for Genomics & Health (GA4GH)coreStrategic or Co-development PartnerFounding contributor to GA4GH open standards including data access, discovery, and cloud computing APIs. Co-author of HL7 FHIR specifications.
  • Microsoft AzuresecondaryTechnology or IntegrationThird-party cloud infrastructure provider for platform hosting. Listed as approved deployment environment in terms of service.
  • Amazon Web ServicessecondaryTechnology or IntegrationThird-party cloud infrastructure provider for platform hosting. Listed as approved deployment environment in terms of service.
  • Google Cloud PlatformsecondaryTechnology or IntegrationThird-party cloud infrastructure provider for platform hosting. Listed as approved deployment environment in terms of service.

Scale indicators14 records

Recent moves6 records

Expansion highlights6 records

DNAstack competitors and assessment

Company assessment

Emerging players

  • Tempus Labs: AI-driven precision medicine company combining clinical and molecular data for oncology and beyond. Adjacent on multi-omics + clinical AI, with stronger commercial reach in US oncology.

Direct peers

  • DNAnexus: Provides a cloud-based genomics data management and analysis platform serving pharma, hospitals, and consortia. Direct competitor in federated/centralized genomics informatics with overlapping pharma and clinical customers.
  • Velsera (formerly Seven Bridges): Cloud genomics and multi-omics analysis platform with biomedical informatics tools for research and clinical use. Overlaps with DNAstack's workflow, tertiary analysis, and pharma-facing capabilities.
  • Fabric Genomics (by GeneDx): Clinical genomics interpretation platform using AI for variant prioritization and rare disease diagnosis. Overlaps with DNAstack's Tertiary Analysis module and rare disease network focus.
  • BC Platforms: Genomics and real-world data platform with federated analytics capabilities serving national genome programs and pharma. Comparable on federated genomics + pharma data partnerships.
  • SOPHiA Genetics: AI-powered genomics platform for clinical interpretation and rare disease/oncology analysis, distributed via hospital network. Competes on AI-driven tertiary interpretation and clinical genomics workflow.
  • Lifebit: Federated genomics and biomedical data platform built on open standards, serving national genomics initiatives and pharma. Closest direct competitor on federated architecture and GA4GH compliance positioning.

Broad incumbents

  • Illumina: Dominant sequencing instrument vendor offering BaseSpace and Connected Software analytics. As an incumbent, it bundles sequencing + analysis and represents the broadest competitive threat in genomics workflows.
  • AWS (HealthOmics): Hyperscaler offering HealthOmics for genomics, transcriptomics, and multi-omics workflows. Competes on integrated cloud + analytics and benefits from existing hospital cloud contracts.
  • Microsoft (Azure Health Data Services / Genomics): Hyperscaler offering Genomics and Health Data Services on Azure, listed as approved DNAstack deployment environment. Bundles compute + analytics at scale and poses a long-term platform threat.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks5 records

Key highlights6 records

Customer concentration

DNAstack social profiles

Digital presence

DNAstack compliance and trust

Trust signal

Compliance5 records

DNAstack financial estimates

Financial estimate

Revenue estimate

Valuation estimate

DNAstack leadership team

Management profile

Number of profiles

Profiles11 records

DNAstack funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

DNAstack M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about DNAstack

What does DNAstack do?

DNAstack builds Omics AI, a federated AI software suite that enables data custodians to connect, protect, and share omics and health data over GA4GH open standards while allowing researchers to make AI-powered discoveries across distributed networks without moving patient data. The suite consists of Workbench (analysis execution), Publisher (data sharing), Explorer (federated discovery), Workflows (curated pipelines), and Tertiary Analysis (Network Intelligence interpretation), and powers disease-specific federated networks such as Viral AI, Neuroscience AI, Rare Disease AI, and HiFi Solves.

Is DNAstack a public or private company?

DNAstack is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was DNAstack founded?

DNAstack was founded in 2014. It employs 11 to 50 people.

Where is DNAstack based?

DNAstack is headquartered in Toronto, Canada, in the North America region.

How does DNAstack make money?

Three revenue lines are on record. Enterprise Software Licensing is the primary driver. The others are saaS Platform Access and professional Services.

Who are DNAstack's main competitors?

Tempus Labs is listed as an emerging player. Direct peers are DNAnexus, Velsera (formerly Seven Bridges), Fabric Genomics (by GeneDx), BC Platforms, SOPHiA Genetics and Lifebit. Broad incumbents are Illumina, AWS (HealthOmics) and Microsoft (Azure Health Data Services / Genomics).

Does DNAstack have an API?

Yes. DNAstack exposes a public API. Developer documentation is at docs.omics.ai.

What industry is DNAstack in?

DNAstack's product category is Genomics Software Platform. Its primary akta.pro industry code is HLAGAJAD, Bioinformatics & Multi-omics Analysis Software, with a secondary code of HLAGANAI, Bioinformatics, Multi-Omics Data Analysis & Interpretation Services. Its NAICS code is 5132 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
GlobeNewswireGlobal AI and Omics Sector Fueled by Precision Medicine and Deep Learning InnovationsThe AI in omics studies market is experiencing substantial growth, expanding from $1.23 billion in 2025 to a projected $5.55 billion by 2030 with a 35% compound annual growth rate, driven by demand for precision medicine, AI-powered drug discovery, and cloud-based multi-omics data integration platforms. Renovaro Biosciences Ltd. acquired Gedi Cune Intl Ltd. in September 2023 to strengthen its advanced regenerative therapies and multi-omics data management capabilities, while DNAstack launched its Omics AI suite to accelerate omics research with real-time analytics and global collaboration tools.GlobeNewswirePacBio Announces First Quarter 2026 Financial ResultsPacBio reported Q1 2026 revenue of $37.2 million, up from $37.2 million in Q1 2025, with consumable revenue at $21.8 million. The company posted a GAAP net loss of $8.3 million, down from $426.1 million a year earlier, and plans to roll out SPRQ-Nx to all Revio customers later this month.openPR.comOntario-Based DNAstack Leads Sovereign AI for Genomics and Health with Goal of Making Canadians Healthier and Reducing Strain on our Healthcare SystemDNAstack, a Toronto-based genomics data company, has developed a federated AI architecture that enables analysis of health and genomic data without centralizing sensitive patient information, maintaining sovereign institutional control. The company operates a global partnership with PacBio (NASDAQ: PACB) across seven production networks on four continents, processing more than 100,000 samples annually and delivering AI-powered disease diagnosis and precision treatment matching. The announcement aligns with Canada's $2-billion Sovereign AI Compute Strategy and Canadian Genomics Strategy, positioning Ontario as a hub for precision medicine with 100% Canadian-owned intellectual property.TradingViewPacBio and DNAstack Collaborate on Global HiFi Genome Network HubPacBio announced a collaboration with DNAstack to launch the world's first global federated dataset of HiFi whole genome sequencing data through the HiFi Solves Global Consortium, enabling researchers to securely analyze harmonized genomic datasets across institutions worldwide without centralizing sensitive patient data. The consortium has grown to nearly 30 clinical and research institutions across 15 countries, collectively connecting or committing more than 10,000 HiFi whole genome sequences. The partnership extends PacBio's HiFi sequencing platform into large-scale international research networks, reinforcing long-term adoption potential in rare disease genomics and creating a recurring ecosystem opportunity for PacBio.GlobeNewswirePacBio and DNAstack Launch First Global Federated HiFi Whole Genome Dataset to Accelerate Rare Disease ResearchPacBio and DNAstack announced a collaboration to launch the world's first global federated dataset of HiFi whole genome sequencing data for rare disease research. The HiFi Solves Global Consortium includes nearly 30 institutions across 15 countries, with over 10,000 sequences connected or committed. The platform enables secure international research while keeping data under institutional control.Stock TitanPacBio, DNAstack launch global HiFi genome dataPacBio and DNAstack have launched the world's first federated HiFi whole genome sequencing dataset through the HiFi Solves Global Consortium, enabling secure international research collaboration while maintaining institutional data control. The consortium brings together nearly 30 clinical and research institutions across 15 countries and has connected or committed to connect more than 10,000 HiFi whole genome sequences for rare disease research. The initiative addresses challenges in genomic data sharing by enabling cross-border analysis while preserving data sovereignty and regional compliance requirements.DnastackA federated insights platform for omics and health dataDNAstack promotes its Omics AI software suite, a platform designed to facilitate federated analysis of omics and health data while ensuring compliance with open industry standards like those from the Global Alliance for Genomics & Health. The company highlights its role in powering global research networks, such as Viral AI which processed 1.6 million SARS-CoV-2 genomes, and notes recent industry recognitions including the 2024 Health Privacy Leadership Award.DnastackDNAstack-led Consortium Launches $17.5M Initiative to Advance AI in Genomics and HealthDNAstack-led consortium launched the Canadian Platform for AI in Health, a $17.5M initiative designed to expand software for AI-powered discoveries in genomics and healthcare. The project utilizes DNAstack's Omics AI platform to break down data silos through a federated model, enabling secure training of AI models across distributed datasets without moving sensitive data. Key partners including PacBio, SickKids, Autism Speaks, Valence, and DIGITAL are collaborating to establish national and international AI infrastructure for health research.YahooDIGITAL celebrates continued investments in Canadian genomicsDIGITAL announced its co-investment in the Canadian Platform for AI in Health, led by DNAstack, to accelerate AI-driven genomics software. The initiative, with partners including SickKids and PacBio, aims to analyze distributed health data. DIGITAL's genomics portfolio totals $83 million, projecting over $300 million in incremental five-year revenue growth.